补肾通络法治疗绝经后骨质疏松症的研究
|
摘要
绝经后骨质疏松症(PMOP)是绝经后妇女的常见病和多发病,本文通过查阅大量古今文献后,系统整理和归纳了现代医学对PMOP的发病机制、诊断和治疗的研究情况。现代医学治疗PMOP的药物一般分为两类：一类为抑制骨吸收、防止骨丢失、维持骨量的药物,如钙剂、雌激素、降钙素、双膦酸盐及活性维生素D(钙三醇)等；另一类为促进骨形成、增加骨密度的药物,如雄激素、氟化物、钙制剂、生长激素、合成蛋白同化激素等。虽然现代医学在防治PMOP取得了较大进展,具有疗效显着,见效快,服用方便等优点,但其副作用较大,有的药物长期服用可能具有诱发癌变等风险,这些副作用也一直困扰着人们。
古代中医虽然没有绝经后骨质疏松症这一病名,但相关描述并不少见。尤其是近年来随着中医药对PMOP研究的逐渐深入,对其中医病因病机的论述较多,现在一般认为其病因病机多与肾精亏虚、脾胃虚弱、肝郁血虚、瘀血阻滞、感受外邪等有关。治疗方法既有专方专药,又有分型施治、序贯治疗、饮食疗法等,均取得很好的疗效。
本文在整理和归纳古今大量有关PMOP论述的基础上,在导师的指导下,认为肾虚血瘀是本病的基本病机,提出以补肾通络法为治疗本病的基本方法。研究对象是本人在台湾的门诊患者,收集30例符合诊断标准的病例。治疗方法：肾阳虚兼瘀阻证用右归丸加紫河车、骨碎补、鸡血藤、怀牛膝；肾阴虚兼瘀阻证用左归丸加紫河车、骨碎补、鸡血藤；服药时间为3个月,同时结合饮食调养。结果发现30例患者的主症均治愈或明显改善,临床治疗评估有效率达100%。显示补肾壮骨,益精填髓,兼以活血化瘀通络法能治疗因为骨质疏松症引发之腰背膝腿疼痛等各种症状,值得我们以后进一步深入研究。
Postmenopausal osteoporosis (PMOP) is a common and frequently encountered disease. After a systematic review of plenty of ancient and modern literatures, this paper aims to present a research summary of pathogenesis, diagnosis and treatment of PMOP from the perspective of modern medicine. Western medical drugs for the treatment of PMOP are classified into two groups:one is to inhibit osteolysis, prevent bone loss and maintain bone mass, like calcium, estrogen, thyrocalcitonin, bisphosphonates and activated vitamin D (calcitriol); the other is to promote bone formation, increase bone density, like androgen, fluoride, growth hormone and synthesized protein anabolic hormone. It is admitted that modern medicine has made great progress on the treatment of PMOP, which has quick and obvious effects and is convenient in use. However, modern medicine has side effects which bother people all along as long-term use of drugs may increase the risk of canceration.
There's no certain name for PMOP in Chinese medicine, but related descriptions could be found, especially further research on PMOP from the perspective of Chinese medicine have been carried out in recently years. Currently the pathogenesis of PMOP is considered to be related to the deficiency of kidney essence, deficiency of spleen and stomach, stagnation of liver qi and blood, obstruction of blood stasis and attack of pathogenic factors. Various treating methods are found effective like specific prescriptions and drugs, treatment based on syndrome patterns, sequential therapy and dietotherapy.
This paper believes that the pathogenesis of PMOP is the kidney deficiency and blood stasis on the basis of collected literatures, thus proposing that the basic treating method is to tonify the kidney and remove blood-stasis in channels. Thirty subjects were my outpatients in Taiwan's clinic collected on the basis of diagnostic criteria of PMOP. Method:You Gui Wan (restoring the right kidney bolus) plus zi he che (placenta hominis), gu sui bu (Rz Drynari), ji xue teng (Canlis Milletliae) and huai niu xi (Rx Achyranthis Bidentatae) was for patients with kidney yang deficiency and blood stasis; Zuo Gui Wan (restoring the left kidney bolus) plus zi he che (placenta hominis), gu sui bu (Rz Drynari), ji xue teng (Canlis Milletliae) and huai niu xi (Rx Achyranthis Bidentatae) was for patients with kidney yin deficiency and blood stasis. Both groups received treatment for3months, supported by dietotherapy. Result:Main syndromes of 30patients were cured or significantly improved. The evaluation of clinical efficacy reached100%. This result indicates that the method to tonify the kidney and essence-blood, strengthen bones, promote blood circulation and remove blood stasis should be further studied as lumbago and back pain, gonyalgia and skelalgia caused by PMOP could be released after treatment.
古代中医虽然没有绝经后骨质疏松症这一病名,但相关描述并不少见。尤其是近年来随着中医药对PMOP研究的逐渐深入,对其中医病因病机的论述较多,现在一般认为其病因病机多与肾精亏虚、脾胃虚弱、肝郁血虚、瘀血阻滞、感受外邪等有关。治疗方法既有专方专药,又有分型施治、序贯治疗、饮食疗法等,均取得很好的疗效。
本文在整理和归纳古今大量有关PMOP论述的基础上,在导师的指导下,认为肾虚血瘀是本病的基本病机,提出以补肾通络法为治疗本病的基本方法。研究对象是本人在台湾的门诊患者,收集30例符合诊断标准的病例。治疗方法：肾阳虚兼瘀阻证用右归丸加紫河车、骨碎补、鸡血藤、怀牛膝；肾阴虚兼瘀阻证用左归丸加紫河车、骨碎补、鸡血藤；服药时间为3个月,同时结合饮食调养。结果发现30例患者的主症均治愈或明显改善,临床治疗评估有效率达100%。显示补肾壮骨,益精填髓,兼以活血化瘀通络法能治疗因为骨质疏松症引发之腰背膝腿疼痛等各种症状,值得我们以后进一步深入研究。
Postmenopausal osteoporosis (PMOP) is a common and frequently encountered disease. After a systematic review of plenty of ancient and modern literatures, this paper aims to present a research summary of pathogenesis, diagnosis and treatment of PMOP from the perspective of modern medicine. Western medical drugs for the treatment of PMOP are classified into two groups:one is to inhibit osteolysis, prevent bone loss and maintain bone mass, like calcium, estrogen, thyrocalcitonin, bisphosphonates and activated vitamin D (calcitriol); the other is to promote bone formation, increase bone density, like androgen, fluoride, growth hormone and synthesized protein anabolic hormone. It is admitted that modern medicine has made great progress on the treatment of PMOP, which has quick and obvious effects and is convenient in use. However, modern medicine has side effects which bother people all along as long-term use of drugs may increase the risk of canceration.
There's no certain name for PMOP in Chinese medicine, but related descriptions could be found, especially further research on PMOP from the perspective of Chinese medicine have been carried out in recently years. Currently the pathogenesis of PMOP is considered to be related to the deficiency of kidney essence, deficiency of spleen and stomach, stagnation of liver qi and blood, obstruction of blood stasis and attack of pathogenic factors. Various treating methods are found effective like specific prescriptions and drugs, treatment based on syndrome patterns, sequential therapy and dietotherapy.
This paper believes that the pathogenesis of PMOP is the kidney deficiency and blood stasis on the basis of collected literatures, thus proposing that the basic treating method is to tonify the kidney and remove blood-stasis in channels. Thirty subjects were my outpatients in Taiwan's clinic collected on the basis of diagnostic criteria of PMOP. Method:You Gui Wan (restoring the right kidney bolus) plus zi he che (placenta hominis), gu sui bu (Rz Drynari), ji xue teng (Canlis Milletliae) and huai niu xi (Rx Achyranthis Bidentatae) was for patients with kidney yang deficiency and blood stasis; Zuo Gui Wan (restoring the left kidney bolus) plus zi he che (placenta hominis), gu sui bu (Rz Drynari), ji xue teng (Canlis Milletliae) and huai niu xi (Rx Achyranthis Bidentatae) was for patients with kidney yin deficiency and blood stasis. Both groups received treatment for3months, supported by dietotherapy. Result:Main syndromes of 30patients were cured or significantly improved. The evaluation of clinical efficacy reached100%. This result indicates that the method to tonify the kidney and essence-blood, strengthen bones, promote blood circulation and remove blood stasis should be further studied as lumbago and back pain, gonyalgia and skelalgia caused by PMOP could be released after treatment.
引文
[1]朴俊红,庞莲萍,刘忠厚,等.中国人口状况及原发性骨质疏松症诊断标准和发生率[J].中国骨质疏松杂志,2002,8(1)：1-7
[2]帅平,程幼夫,刘玉萍,等.成都地区普通人群骨密度与骨质疏松流行现状分析[J].四川医学,2012,33(9)：1680-1682
[3]吴骞.血浆晚期蛋白氧化产物水平与妇女绝经后骨质疏松关系的初步探究[D].南方医科大学硕士学位论文,2011,4
[4]Sasse T,Becker P Dorfling P.TGF-β1mRNAexpression and proliferation of human osteooblastic cells in momosteoporotic and osteoporotic women under influence of TGF-β1mRNA and IGF-I.Calcified Tissue Int,1998.62(2):140-149
[5]薛昊罡,冷冰,马恩元,等.雌激素水平与绝经女性并发骨质疏松症的相关性研究[J].中国妇幼保健,2011,26(26)：4106-4108
[6]Marc J Prezel jJ Kanel R, et al. Association.of vitamin D receptor gene polymorphism with bone mineral density in Slovenian postmenopausal women Gynecol Fndocrino 1,2000.14(1):60-64
[7]Kurabayashi T, Tomita M, Matsushita H, et al. Association of vitamin D and estrogen receptor gene polyrrorphism with the effect of hormone replacement therapy on bone mineral density in Japanese women.AmJObstet Gynecol,1999.180 (5):1115-1120
[8]Salmen postmenopausal bone loss is associated with Pvu'estrogen receptor gene polyrmrphism.i.n Finnish warren:effect of hormone replacgnent therapy:JBone Mines Res,2000.15 (2):318-321
[9]Ogawa S, Hosoi T, Sniraki M, et al. Associatin of estrogen receptor beta gene polymorphisn with bone mineral density. Biochem Biophys Res Commun,2000,269 (2):537-541
[10]Bagger YZ, Jorgenson HL, Heegaard AM, et al. No major effect of estrogen receptor gene polymazphisn on bone mineral density or bone loss in postmenopausal Bone,2000.26(2):111-116
[11]Bertoldo F, Arguma I, Furlan F et al. Transforming growth factor-beta1 gene polymorphism bone turnover and bone mass in Italian postmenopausal maven. J Bone Miner Res,2000.15(4):634-639
[12]LangdalZl.氏 L.okke E, Carstens M, et al. Osteoporotic fract}mes are associated with an 86- base pair repeat polyrmrphism in the interlenkin-1-receptor antagonist gene but not with polymorphism in the interlenkin-1 beta gene. J Bone Res,2000,15(3):402-414
[13]Mare J, Prezel j JKomel R,et al. Association of vitamin D receptor gene polymorphism with bone mineral dehsi}y in Slovenian postmenopausal warren. Gynecol Endocrinol,2000,14(1):60-64
[14]杨潮武,钟志甘,姚春花.吸烟对绝经后妇女骨密度和骨代谢指标的影响：配对研究[J].中国临床康复,2004,8(24)：5068-5069
[15]Danz AM,ZillermannA, Schidermaier U,Kleih D, Schoau E. The effect of a specific strength-development exercise on bone mineral density in perimer}pausal and postmenopeusql women J Womens Health 2008.7(6):701-709
[16]孙青凤.绝经后骨质疏松症的研究进展[D].成都中医药大学硕士学位论文,2005,14
[17]廖二元,邓小戈,周智广,等.尼尔雌醇加孕激素治疗绝经后骨质疏松症的研究[J].中华内分泌代谢杂志,2002,18(2)：95-98
[18]董玉芳,陈方焘,张青.超低剂量雌激素阴道给药治疗绝经后骨质疏松症[J].现代中西医结合杂志,2009.9(2)：1986
[19]史则峡,李永佳,周瑾.结合雌激素辅以乐力钙治疗绝经后骨质疏松症临床观察[J].实用妇产科杂志,2001,17(4)：239
[20]周维,周丽萍,彭文湃,等.HTR加用雄激素对绝经后妇女骨代谢影响的探讨[J].中国妇幼保健,2004,19(1)：16-18
[21]Heidi D.Postmenopausal hormonere placeneng therapy:scientific review JAMA,2002.288:872-881
[22]孙青凤.绝经后骨质疏松症的研究进展[D].成都中医药大学硕士学位论文,2005,20
[23]汪远金,许金林,张杰,等.大豆异黄酮对去卵巢大鼠骨质疏松症防治作用的研究[J].中国中医药科技,2004,11(3)：256-157
[24]Murata M, Midorikawa K, KohM, a tal. Genistein and daidzein in induce cell prollife ration and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs. Biochemistry,2004,9(43):2569-2577
[25]陈德才,卢春燕.绝经后骨质疏松症的循证治疗[J].中国循证医学杂志,2004,4(7)：494
[26]张宏红,吴春维,何秀华.雌激素加钙剂与钙剂对比治疗绝经后妇女骨质疏松症的骨密度测定分析[J].贵州医药,2001,25(10)：904-905
[27]徐栋梁,李佛保,万勇.等.活性维生素D3加钙剂治疗妇女骨质疏松症2年疗效观察[J].中国骨质疏松杂志,1998,4(2)：62-65
[28]王建东,章哗,吴小峰,等.益盖宁治疗骨质疏松症的疗效观察[J].临床骨科杂志,2002.6(3)：199-200
[29]詹克勇,王长江,刘树琴,等.鲑鱼降钙素鼻喷剂治疗绝经后骨质疏松疗效观察[J].安徽医科大学学报,2002.37(3)：203-205
[30]Chapuy MC, Arlot ME, Duboeuf F,Brun J, Crouzet B, Arbaud S, Delmas PD, Meunier PJ VitaminD3 and calciurt to prevent hipfi}nct}mes in elderly women[J]N Engl J Med,1992.327(23):16 371642
[31]Lips P, WilcoC, Graafcnans N6, Bezemer PD, Boater LM Vitmin D supplementation and fracture in cadence in elderly persons [J] Ann Intern Mbed,1996.124(4):400-406
[32]AnnC, GeorgeW, Andrew W, Lauren G, Nicole Z, VinianR, Dennis B, JonathanA,Beverley S, Peter T Gorcbn G Meta Analysis of Alenck}onate for the Treatment of Post menopausal Women[J]Endocrine Reviews,2002.23 (4):508516.
[33]Luckey M M, Cilchrist N, Bone H G, et al. Therapeutic equivalence of alenor}.te 35 milligrams once weekly and 5 milligrams daily in the prevention of postmenopausal osteoporosis[J].ObstetGynecol, 2003.101(4):711
[34]傅文贞,柯耀华,汪纯,等.阿仑膦酸钠治疗绝经后骨质疏松的效果及与低密度脂蛋白受体相关蛋白5 基因N740N多态性的关系研究[J].中国全科医学,2012,15(8B)：2646-2648
[35]Lufkin E G, Whitaker M D, Nickelsen T, et al. Treatment of established PostmenoPausal osteoprosis with raloxifene:a randomized trial[J]. J Bone Miner Res,1998.13(11):1747
[36]Khovidhunkit W,Shoback DM Clinical effects of raloxifene hydrochloride in warn Ann [J]Intern Med,1999.130(5):431
[37]Delmas PD,_Ensrud KE, Adachi JD, et al. MultiPle outcaoes of raloxifene evaluation investigator. E,ficacy of raloxifene on vertebral fract}e risk reduction in PostmenoPausal women with osteoprosis:four-year results fran a randomized clinical trial[J]. Clin Endocrinol Metab,2002.87(8):3609
[38]单海静摘译.李中东校.雷洛昔芬致血栓栓塞[J].药物不良反应杂志,2003.(2)：134
[39]Zheng SR, WuYY, ZL, etal. A randomized clinical trial to study the effects of Ralxifene hudrc}hlride on bone mineral desity,biochemical markers of bone metabolise and serum lipids wanen.Chin [J]Obset Gynecol, 2003.38:266-269
[40]连帆,王于,杨岫岩,等.绝经后骨质疏松治疗方法的近期疗效观察与比较[J].中山大学学报(医学科学版),2011,32(3)：379-382
[41]睦承志.肾主骨生髓与绝经后骨质疏松症病理基础关系[J].中医药通报,2007,6(1)：38-40
[42]武密山,李恩,赵素芝,等.补肾方药对实验性骨质疏松大鼠垂体—甲状腺及骨密度的影响[J].中国临床康复,2005,9(11)：187-189
[43]龚张斌,姚建平,金国琴.补肾方药对老年大鼠下丘脑—垂体—肾上腺皮质所属组织结构形态变化的影响[J].辽宁中医杂志,2006,33(1)：103-104
[44]金珉廷,郑洪新.中医肾藏精生髓主骨理论与骨质疏松[J].辽宁中医药大学学报,2009,11(3)：35-36
[45]徐晓东,郑洪新.肾虚与骨质疏松症[J].辽宁中医药大学学报,2007,9(4)：45-46
[46]严樟根.吕凤祥治痹经验[J].浙江中医药大学学报,2006,30(4)：394
[47]夏东胜,郭志强.101例绝经后骨质疏松患者的中医证候分析[J].北京中医,2001,20(2)：11-13
[48]徐祖健,汪付,尹思源,等.绝经后妇女原发性骨质疏松症中医辨证分型与BMD的相关性研究[J].中国中医骨伤科杂志,2008,16(9)：4-5
[49]张荣华,朱晓峰.脾肾两虚兼血瘀与原发性骨质疏松关系的探讨[J].四川中医,2003,21(5)：11-12
[50]章薇,金华.养血调肝方防治绝经后骨质疏松症的研究思路[J].中国中医骨伤科杂志,2005,13(3)：52-53
[51]杜斌,周止.中医药辨证治疗骨质琉松症的临床研究[J].中国中医骨伤科杂志,2004,12(1)：55-57
[52]文晢双,王志忠,朱毅.肝郁患者血清T、E2、PRL检测及其临床意义[J].湖北中医学院学报,2000,2(2)：27-29
[53]滕秀香.122例卵巢早衰患者中医证候分析及致病因素调查[J].中国中医药信息杂志,2008, 15(4)：18-20
[54]徐元雯.管窥肝郁证的现代研究[J].江西中医学院学报,2007,19(2)：99-100
[55]何铭涛,梁祖建.庄洪教授从瘀论治骨质疏松症经验介绍[J].新中医,2007,39(9)：18-19
[56]睦承志,周军,刘志坤.绝经后骨质疏松症血瘀病机的客观初步论证[J].中医研究,2005,18(1)：30-33
[57]睦承志,刘志坤,陈少玫,等.绝经后骨质疏松症血瘀病机的微观分子生物学论证[J].中医研究,2005,18(4)：10-23
[58]眭承志,王彦伟,刘志坤,等.血瘀证在绝经后骨质疏松症中的量化研究[J].中医药通报,2005,4(2)：32-34
[59]姚新苗.益骨汤含药血清对成骨细胞增殖和ALP影响[J].浙江中医药大学学报,2007,31(2)：158-159
[60]金珉廷,郑洪新.骨质疏松症的中医体质学特征[J].中华中医药学刊,2009,27(4)：824-826
[61]孙益,童培建,肖鲁伟.绝经后骨质疏松症与中医体质的相关性[J].中医杂志,2009,50(8)：696-698
[62]齐国艳,齐玉春.不同剂型雌激素治疗绝经后骨质疏松症患者骨密度及血清性激素水平观测[J].中国临床康复,2003,7(5)：809
[63]杨爱武,张荣华,蔡宇,等.老年性骨质疏松症中医病机及中药防治机理探讨[J].陕西中医,2004,25(3)：237-239
[64]陈丽琛,唐年亚,邱幸凡,等.骨质疏松症的病因病机及其防治探讨[J].山西中医,2007,23(1)：4-6
[65]尚德阳,郑洪新.基于“络病”理论的骨质疏松症病机探微[J].中华中医药学刊,2008,26(2)：344-345
[66]马伟,牟慧琴,马占洋.绝经后骨质疏松症中医病因病机研究概况[J].中医杂志,2012,53(13)：1152-1154
[67]杨洪彬,徐祖健,汪新象,等.绝经后女性骨质疏松症中医证型及证候分布规律的研究[J],四川中医,2009,27(4)：23-25
[68]胡志俊,王世伟,刘文波,等.骨质疏松的中医辨证分型研究[J].中国中医骨伤科杂志,2012,20(1)：23-25
[69]施杞,王和鸣.骨伤科学[M].北京：人民卫生出版社,2001：1704
[70]杜斌,闵正.中医药辨证治疗骨质疏松症的临床研究[J].中国中医骨伤科杂志,2004,12(1)：55-56
[71]刘峰,梁翔彭太平.中医药辨证治疗骨质疏松症128例[J],实用中西医结合临床,2005,5(4)：52
[72]蔡永江,张秀婷.中压对骨质疏松症的辨证与防治[J].中医中药,2008,46(19)：82-84
[73]朱芸菌.原发性骨质疏松症中医证候特征探析[J].亚太传统医药,2006,(2)：56-57
[74]吴健雄,黄崇博,蔡桦,等.骨质疏松症中医证型与细胞因子、性激素、骨钙素的相关性临床研究[J]中国中医骨伤科杂志,2008,16(6)：1-9
[75]穆刚,王平,张君涛.对原发性骨质疏松症证型实质的探讨[J]中国中医骨伤科杂志,2006,16(1)：66-67
[76]刘建宁,王晔.中医药治疗绝经后骨质疏松症概况[J].中国中医基础医学杂志,2011,15(4)：465-466
[77]林举择,陈升恺,罗家栋.补骨脂注射液对体外培养大鼠成骨细胞增殖的影响[J].中医正骨,2004,16(6)：6-8.
[78]殷晓雪,陈仲强,党耕盯,等.淫羊藿苷对人成骨细胞增殖与分化的影响[J].中国中药杂志,2005,30(4)：289-291.
[79]于波,杨久山,刘岩,等.淫羊藿苷对人成骨细胞的作用[J].中医正骨,2006,18(6)：17-18.
[80]张秀珍,杨黎娟.淫羊藿甙对大鼠成骨细胞护骨素、RANKL表达的影响[J].中华内分泌代谢杂志,2006,22(3)：222-225.
[81]朱志刚,宋利格,张秀珍.淫羊藿总黄酮对去卵巢大鼠骨组织Ⅰ型胶原代谢及组织蛋白酶K表达的影响[J].中华内分泌代谢杂志,2006,22(3)：213-217.
[82]齐振熙.生髓饮Ⅱ号治疗绝经后骨质疏松症36例[J].福建中医学院学报,2000,10(3)；29-30
[83]邓伟民,贺扬淑,冯永佳.补肾中药治疗绝经后骨质疏松症疗效分析[J].中国骨质疏松杂志,1997.3(1)：64-66
[84]陈根生,蒋奇平,韩允柱,等.筋骨再造合剂治疗绝经后骨质疏松症临床观察[J].中国中医骨伤科杂志.2001.9(6)：49-51
[85]何文扬,蔡雪芬.狗脊散加减治疗绝经后骨质疏松症113例[J].中医药学刊,2004,22(7)：1316-1317
[86]史炜缤,曲克服.骨松Ⅰ号治疗绝经后骨质疏松症的初步临床观察[J].中国骨伤,1996,9(6)：3-5
[87]赵光,徐则李,邵琼星,等.利维爱及中药补肾法防治绝经后妇女骨质疏松症的临床对比研究[J].中国骨质疏松杂志,2004,10(3)：337-339
[88]刘忠厚.骨质疏松学[M].北京：科学出版社,1998：46
[89]陈华圣.绝经后骨质疏松症中医病机探讨及防治法则[J].四川中医,1998,16(1)：8-9
[90]齐振熙.辨证治疗绝经后骨质疏松症[J].中国中医骨伤科杂志,1998,6(3)：28-29
[91]陈维静,刘新梅.中医辨证治疗原发性骨质疏松症(附109例报告)[J].中医药研究,1999.15(3)：29-31
[92]梁克玉,魏玉玲.中药增骨汤序贯疗法治疗绝经后骨质疏松症[J].中医正骨,1999,11(1)：9-10
[93]栗明拥.骨质疏松症调养与护理[M].北京,中国中医药出版社,1999：37
[94]潘文宇,李艳慧.针灸加火针治疗绝经后骨质疏松56例[J].中医药学刊,2002,21(5)：811
[95]针灸治疗绝经后骨质疏松症疗效确切[J].册东中医杂志,1999,181/2：234
[96]贾育松.穴位注射治疗绝经后骨质疏松症初探[J].中国骨质疏松杂志,2003,9(2)：171-172
[97]倪克锋,詹强,周翔,等.足部反射区按摩治疗绝经后骨质疏松症40例[J].浙江中医杂志,2002,(6)：246
[98]崔三生.一种新型ADL量表可行性研究[J].中国康复,1996.11(4)：153
[99]刘飞,任平,徐雅丽,等.艾灸防治绝经后骨质疏松的实验研究[J].中国老年学杂志,2012,32(8)：1655-1656
[100]胡平安,石宝营,胡金安.补肾活血汤并离子透入治疗骨质疏松性腰背痛28例[J].四川中 医.1994,12(9)：43-44
[101]叶安娜.补肾壮骨汤治疗老年性骨质疏松症60例临床观察[J].新中医,2012,30(7)：52.
[102]张乃钙,韩旭华.中西医结合治疗绝经后骨质疏松症的研究[J].中国中医骨伤科杂志,1995,3(1)：14-16.
[103]钱祖稀.中药配合雌激素治疗绝经后骨质疏松症60例[J].实用中医杂志,1999,15(8)：31.
[104]李隆敏,周樱,邵幸署.丹参酮防治绝经后骨质疏松症[J].中国骨质疏松杂志,1996,2(1)：78.
[105]张琥,石关桐,徐震球.脉冲电磁场治疗骨质疏松症机制探讨[J].现代康复,2001,5(5)：74
[106]孙雯敏,王先平,张秀云,等.脉冲电磁场治疗绝经后骨质疏松症肠46例临床观察[J].河北医学,2001.7(11)：979-981
[107]陈兵,姜友昭,万萍,等.脉冲电磁场对绝经后骨质疏松症患者骨密度及腰背痛改善效果[J].中国临床康复,2004.8(3)：504-505
[108]Kudla}ekyS, Pietsch}n F, Bernecja} P, etal. The irt}act of a senior dancing program on spinal and peripheral bone mass.AmJ Phys Med Rehabi 1,1997,76:47781
[109]Bemben DA.Exercise interventions for osteoporosis prevention in postmenopausal women J Okla State Nod Assoc,1999,92:66-70.
[110]乔玉成.Cochrane评价：绝经后妇女骨质疏松运动干预效果的比较[J].中国体育科技,2010,46(6)：121-128
[111]黄妹,孟萍,蔡红卫.低频脉冲电磁场与雌激素联合应用治疗绝经后骨质疏松症[J].中国临床康复,2003.7(5)：1399-1400
[112]卓铁军,欧阳钢,申志祥,等.针药结合对绝经后骨质疏松症骨密度的影响[J].针灸临床杂志.2000,16(n)：1-2
[113]李锋.综合治疗绝经后骨质疏松症58例疗效观察[J].中医正骨,2003,15(8)：23
[114]袁慧,汪绿萍,李煜明.耳压加钙剂治疗绝经后骨质疏松症45例[J].南京中医药大学学报(自然科学版),2001.17(4)：247
[115]钱祖稀.中药配合雌激素治疗绝经后骨质疏松症60例[J].实用中医杂志,1999,15(8)：31
[116]徐栋梁,李佛保,杨忠汉,等.DAsRR程序治疗131例绝经后骨质疏松症妇女的5年临床研究[J].中国骨质疏松杂志,2002,8(4)：321-323
[117]陈玉平,刘雪琴,蔡德鸿.对社区中老年人骨质疏松症的健康教育效果评价[J].护理研究,2006,20(171)：650-652.
[118]段永敏.中西医结合治疗绝经后骨质疏松症32例[J].深圳中西医结合杂志,2010,20(1)：48-50.
[119]刘梅三.绝经期妇女骨质疏松症的自我预防及护理指导[J].实用医技杂志,2005,12(5)：911.
[120]孙美芝,陈燕.绝经后妇女骨质疏松症防治研究进展[J].齐鲁护理杂志,2012,18(13)：55-56
[121]杨霏,秦开蓉,范绮平,等.健康教育对绝经后骨质疏松症患者的影响[J].中国康复,2012,27(4)：308-309
[122]廖二元,伍贤平,罗湘杭,等.绝经后骨质疏松症的发病机制和临床诊断与治疗[J].中国科技奖 励,2008,(10)：46-47
[123]张亚军,刘忠原,张鹏.绝经后骨质疏松症流行病学研究进展[J].中国骨质疏松杂志,2010,16(3)：229-234.
[124]杨黎娟.雌激素抗骨质疏松的研究进展[J].国外医学内分泌分册,2004,31(2)：84-87
[125]廖琳,黎学松,蔡全辉,等.补肾生髓法治疗绝经后骨质疏松症的临床研究[J].中国中医药信息杂志,2004,11(4)：287-290
[126]林文彬：骨质疏松症的中医证型研究与探讨[J].台湾：中国中医临床医学杂志,2004：10(3)
[127]孙青凤.绝经后骨质疏松症的研究进展[D].成都中医药大学硕士学位论文,2005,31-32
[128]潘子昂.我国骨质疏松研究现状和展望[J].中国骨质疏松杂志,2005,10(1)：68
[129]邓伟民,贺扬淑,冯永佳.补肾中药治疗绝经后骨质疏松症疗效分析[J].中国骨质疏松杂志,1997,3(1)：64
[130]冯世纶,夏志道,吴文才.治痹补骨丹治疗绝经后骨质疏松症47例临床观察[J].中国骨质疏松杂志,1997,3(2)：59
[131]工菖生,许昕,金敬善,等.益肾坚骨丸治疗女性骨质疏松症的临床研究[J].中国骨质疏松杂志,1997,3(4)：61
[132]杜靖远,杨家玉,洪光祥,等.补肾密骨液防治绝经后妇女代谢性骨质丢失的初步临床研究[J].中国中医骨伤科,1994,2(4)：13
[133]陈大蓉,唐显着,郑坤渝,等.中药护骨合剂防治绝经后骨质疏松症的临床研究[J].中医杂志,1994,35(6)：359
[134]刘和娣,李恩,刘昆.补肾中药对骨质疏松大鼠CaBp-D9k基因及表达的影响[J].中国骨质疏松杂志,1996,2(3)：62
[135]崔家鹏,郑洪新,刘景峰,等.补肾中药对肾虚骨质疏松症大鼠红细胞膜PKC、Ca2+-Mg2+-ATP酶活性影响的实验研究[J].中国骨质疏松杂志,1997,3(3)：66
[136]杨燕萍,沈霖,杜靖远,等.补肾密骨液对切除卵巢大鼠实验性骨质疏松症骨质无机元素的影响[J].中国中医骨伤科杂志,1994,2(5)：10
[137]李恩,陶静华,刘和娣,等.补肾方药治疗骨质疏松的实验研究与临床观察[J].中国骨质疏松杂志,1996,2(4)：65
[138]李安东,贾冬,李绿华,等.骨疏康冲剂的药理学实验研究[J].中国骨质疏松杂志,1996,2(3)：55
[139]梁克玉,魏玉玲,郭邦富,等.中药增骨序贯疗法治疗绝经后骨质疏松症—附120例临床观察[J].中医正骨,1999,11(1)：9
[140]陈训华,危剑安,陈燕平,等.补肾方药对去卵巢鼠骨质疏松症防治作用的研究[J].中国骨伤,1998，11(2)：12
[2]帅平,程幼夫,刘玉萍,等.成都地区普通人群骨密度与骨质疏松流行现状分析[J].四川医学,2012,33(9)：1680-1682
[3]吴骞.血浆晚期蛋白氧化产物水平与妇女绝经后骨质疏松关系的初步探究[D].南方医科大学硕士学位论文,2011,4
[4]Sasse T,Becker P Dorfling P.TGF-β1mRNAexpression and proliferation of human osteooblastic cells in momosteoporotic and osteoporotic women under influence of TGF-β1mRNA and IGF-I.Calcified Tissue Int,1998.62(2):140-149
[5]薛昊罡,冷冰,马恩元,等.雌激素水平与绝经女性并发骨质疏松症的相关性研究[J].中国妇幼保健,2011,26(26)：4106-4108
[6]Marc J Prezel jJ Kanel R, et al. Association.of vitamin D receptor gene polymorphism with bone mineral density in Slovenian postmenopausal women Gynecol Fndocrino 1,2000.14(1):60-64
[7]Kurabayashi T, Tomita M, Matsushita H, et al. Association of vitamin D and estrogen receptor gene polyrrorphism with the effect of hormone replacement therapy on bone mineral density in Japanese women.AmJObstet Gynecol,1999.180 (5):1115-1120
[8]Salmen postmenopausal bone loss is associated with Pvu'estrogen receptor gene polyrmrphism.i.n Finnish warren:effect of hormone replacgnent therapy:JBone Mines Res,2000.15 (2):318-321
[9]Ogawa S, Hosoi T, Sniraki M, et al. Associatin of estrogen receptor beta gene polymorphisn with bone mineral density. Biochem Biophys Res Commun,2000,269 (2):537-541
[10]Bagger YZ, Jorgenson HL, Heegaard AM, et al. No major effect of estrogen receptor gene polymazphisn on bone mineral density or bone loss in postmenopausal Bone,2000.26(2):111-116
[11]Bertoldo F, Arguma I, Furlan F et al. Transforming growth factor-beta1 gene polymorphism bone turnover and bone mass in Italian postmenopausal maven. J Bone Miner Res,2000.15(4):634-639
[12]LangdalZl.氏 L.okke E, Carstens M, et al. Osteoporotic fract}mes are associated with an 86- base pair repeat polyrmrphism in the interlenkin-1-receptor antagonist gene but not with polymorphism in the interlenkin-1 beta gene. J Bone Res,2000,15(3):402-414
[13]Mare J, Prezel j JKomel R,et al. Association of vitamin D receptor gene polymorphism with bone mineral dehsi}y in Slovenian postmenopausal warren. Gynecol Endocrinol,2000,14(1):60-64
[14]杨潮武,钟志甘,姚春花.吸烟对绝经后妇女骨密度和骨代谢指标的影响：配对研究[J].中国临床康复,2004,8(24)：5068-5069
[15]Danz AM,ZillermannA, Schidermaier U,Kleih D, Schoau E. The effect of a specific strength-development exercise on bone mineral density in perimer}pausal and postmenopeusql women J Womens Health 2008.7(6):701-709
[16]孙青凤.绝经后骨质疏松症的研究进展[D].成都中医药大学硕士学位论文,2005,14
[17]廖二元,邓小戈,周智广,等.尼尔雌醇加孕激素治疗绝经后骨质疏松症的研究[J].中华内分泌代谢杂志,2002,18(2)：95-98
[18]董玉芳,陈方焘,张青.超低剂量雌激素阴道给药治疗绝经后骨质疏松症[J].现代中西医结合杂志,2009.9(2)：1986
[19]史则峡,李永佳,周瑾.结合雌激素辅以乐力钙治疗绝经后骨质疏松症临床观察[J].实用妇产科杂志,2001,17(4)：239
[20]周维,周丽萍,彭文湃,等.HTR加用雄激素对绝经后妇女骨代谢影响的探讨[J].中国妇幼保健,2004,19(1)：16-18
[21]Heidi D.Postmenopausal hormonere placeneng therapy:scientific review JAMA,2002.288:872-881
[22]孙青凤.绝经后骨质疏松症的研究进展[D].成都中医药大学硕士学位论文,2005,20
[23]汪远金,许金林,张杰,等.大豆异黄酮对去卵巢大鼠骨质疏松症防治作用的研究[J].中国中医药科技,2004,11(3)：256-157
[24]Murata M, Midorikawa K, KohM, a tal. Genistein and daidzein in induce cell prollife ration and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs. Biochemistry,2004,9(43):2569-2577
[25]陈德才,卢春燕.绝经后骨质疏松症的循证治疗[J].中国循证医学杂志,2004,4(7)：494
[26]张宏红,吴春维,何秀华.雌激素加钙剂与钙剂对比治疗绝经后妇女骨质疏松症的骨密度测定分析[J].贵州医药,2001,25(10)：904-905
[27]徐栋梁,李佛保,万勇.等.活性维生素D3加钙剂治疗妇女骨质疏松症2年疗效观察[J].中国骨质疏松杂志,1998,4(2)：62-65
[28]王建东,章哗,吴小峰,等.益盖宁治疗骨质疏松症的疗效观察[J].临床骨科杂志,2002.6(3)：199-200
[29]詹克勇,王长江,刘树琴,等.鲑鱼降钙素鼻喷剂治疗绝经后骨质疏松疗效观察[J].安徽医科大学学报,2002.37(3)：203-205
[30]Chapuy MC, Arlot ME, Duboeuf F,Brun J, Crouzet B, Arbaud S, Delmas PD, Meunier PJ VitaminD3 and calciurt to prevent hipfi}nct}mes in elderly women[J]N Engl J Med,1992.327(23):16 371642
[31]Lips P, WilcoC, Graafcnans N6, Bezemer PD, Boater LM Vitmin D supplementation and fracture in cadence in elderly persons [J] Ann Intern Mbed,1996.124(4):400-406
[32]AnnC, GeorgeW, Andrew W, Lauren G, Nicole Z, VinianR, Dennis B, JonathanA,Beverley S, Peter T Gorcbn G Meta Analysis of Alenck}onate for the Treatment of Post menopausal Women[J]Endocrine Reviews,2002.23 (4):508516.
[33]Luckey M M, Cilchrist N, Bone H G, et al. Therapeutic equivalence of alenor}.te 35 milligrams once weekly and 5 milligrams daily in the prevention of postmenopausal osteoporosis[J].ObstetGynecol, 2003.101(4):711
[34]傅文贞,柯耀华,汪纯,等.阿仑膦酸钠治疗绝经后骨质疏松的效果及与低密度脂蛋白受体相关蛋白5 基因N740N多态性的关系研究[J].中国全科医学,2012,15(8B)：2646-2648
[35]Lufkin E G, Whitaker M D, Nickelsen T, et al. Treatment of established PostmenoPausal osteoprosis with raloxifene:a randomized trial[J]. J Bone Miner Res,1998.13(11):1747
[36]Khovidhunkit W,Shoback DM Clinical effects of raloxifene hydrochloride in warn Ann [J]Intern Med,1999.130(5):431
[37]Delmas PD,_Ensrud KE, Adachi JD, et al. MultiPle outcaoes of raloxifene evaluation investigator. E,ficacy of raloxifene on vertebral fract}e risk reduction in PostmenoPausal women with osteoprosis:four-year results fran a randomized clinical trial[J]. Clin Endocrinol Metab,2002.87(8):3609
[38]单海静摘译.李中东校.雷洛昔芬致血栓栓塞[J].药物不良反应杂志,2003.(2)：134
[39]Zheng SR, WuYY, ZL, etal. A randomized clinical trial to study the effects of Ralxifene hudrc}hlride on bone mineral desity,biochemical markers of bone metabolise and serum lipids wanen.Chin [J]Obset Gynecol, 2003.38:266-269
[40]连帆,王于,杨岫岩,等.绝经后骨质疏松治疗方法的近期疗效观察与比较[J].中山大学学报(医学科学版),2011,32(3)：379-382
[41]睦承志.肾主骨生髓与绝经后骨质疏松症病理基础关系[J].中医药通报,2007,6(1)：38-40
[42]武密山,李恩,赵素芝,等.补肾方药对实验性骨质疏松大鼠垂体—甲状腺及骨密度的影响[J].中国临床康复,2005,9(11)：187-189
[43]龚张斌,姚建平,金国琴.补肾方药对老年大鼠下丘脑—垂体—肾上腺皮质所属组织结构形态变化的影响[J].辽宁中医杂志,2006,33(1)：103-104
[44]金珉廷,郑洪新.中医肾藏精生髓主骨理论与骨质疏松[J].辽宁中医药大学学报,2009,11(3)：35-36
[45]徐晓东,郑洪新.肾虚与骨质疏松症[J].辽宁中医药大学学报,2007,9(4)：45-46
[46]严樟根.吕凤祥治痹经验[J].浙江中医药大学学报,2006,30(4)：394
[47]夏东胜,郭志强.101例绝经后骨质疏松患者的中医证候分析[J].北京中医,2001,20(2)：11-13
[48]徐祖健,汪付,尹思源,等.绝经后妇女原发性骨质疏松症中医辨证分型与BMD的相关性研究[J].中国中医骨伤科杂志,2008,16(9)：4-5
[49]张荣华,朱晓峰.脾肾两虚兼血瘀与原发性骨质疏松关系的探讨[J].四川中医,2003,21(5)：11-12
[50]章薇,金华.养血调肝方防治绝经后骨质疏松症的研究思路[J].中国中医骨伤科杂志,2005,13(3)：52-53
[51]杜斌,周止.中医药辨证治疗骨质琉松症的临床研究[J].中国中医骨伤科杂志,2004,12(1)：55-57
[52]文晢双,王志忠,朱毅.肝郁患者血清T、E2、PRL检测及其临床意义[J].湖北中医学院学报,2000,2(2)：27-29
[53]滕秀香.122例卵巢早衰患者中医证候分析及致病因素调查[J].中国中医药信息杂志,2008, 15(4)：18-20
[54]徐元雯.管窥肝郁证的现代研究[J].江西中医学院学报,2007,19(2)：99-100
[55]何铭涛,梁祖建.庄洪教授从瘀论治骨质疏松症经验介绍[J].新中医,2007,39(9)：18-19
[56]睦承志,周军,刘志坤.绝经后骨质疏松症血瘀病机的客观初步论证[J].中医研究,2005,18(1)：30-33
[57]睦承志,刘志坤,陈少玫,等.绝经后骨质疏松症血瘀病机的微观分子生物学论证[J].中医研究,2005,18(4)：10-23
[58]眭承志,王彦伟,刘志坤,等.血瘀证在绝经后骨质疏松症中的量化研究[J].中医药通报,2005,4(2)：32-34
[59]姚新苗.益骨汤含药血清对成骨细胞增殖和ALP影响[J].浙江中医药大学学报,2007,31(2)：158-159
[60]金珉廷,郑洪新.骨质疏松症的中医体质学特征[J].中华中医药学刊,2009,27(4)：824-826
[61]孙益,童培建,肖鲁伟.绝经后骨质疏松症与中医体质的相关性[J].中医杂志,2009,50(8)：696-698
[62]齐国艳,齐玉春.不同剂型雌激素治疗绝经后骨质疏松症患者骨密度及血清性激素水平观测[J].中国临床康复,2003,7(5)：809
[63]杨爱武,张荣华,蔡宇,等.老年性骨质疏松症中医病机及中药防治机理探讨[J].陕西中医,2004,25(3)：237-239
[64]陈丽琛,唐年亚,邱幸凡,等.骨质疏松症的病因病机及其防治探讨[J].山西中医,2007,23(1)：4-6
[65]尚德阳,郑洪新.基于“络病”理论的骨质疏松症病机探微[J].中华中医药学刊,2008,26(2)：344-345
[66]马伟,牟慧琴,马占洋.绝经后骨质疏松症中医病因病机研究概况[J].中医杂志,2012,53(13)：1152-1154
[67]杨洪彬,徐祖健,汪新象,等.绝经后女性骨质疏松症中医证型及证候分布规律的研究[J],四川中医,2009,27(4)：23-25
[68]胡志俊,王世伟,刘文波,等.骨质疏松的中医辨证分型研究[J].中国中医骨伤科杂志,2012,20(1)：23-25
[69]施杞,王和鸣.骨伤科学[M].北京：人民卫生出版社,2001：1704
[70]杜斌,闵正.中医药辨证治疗骨质疏松症的临床研究[J].中国中医骨伤科杂志,2004,12(1)：55-56
[71]刘峰,梁翔彭太平.中医药辨证治疗骨质疏松症128例[J],实用中西医结合临床,2005,5(4)：52
[72]蔡永江,张秀婷.中压对骨质疏松症的辨证与防治[J].中医中药,2008,46(19)：82-84
[73]朱芸菌.原发性骨质疏松症中医证候特征探析[J].亚太传统医药,2006,(2)：56-57
[74]吴健雄,黄崇博,蔡桦,等.骨质疏松症中医证型与细胞因子、性激素、骨钙素的相关性临床研究[J]中国中医骨伤科杂志,2008,16(6)：1-9
[75]穆刚,王平,张君涛.对原发性骨质疏松症证型实质的探讨[J]中国中医骨伤科杂志,2006,16(1)：66-67
[76]刘建宁,王晔.中医药治疗绝经后骨质疏松症概况[J].中国中医基础医学杂志,2011,15(4)：465-466
[77]林举择,陈升恺,罗家栋.补骨脂注射液对体外培养大鼠成骨细胞增殖的影响[J].中医正骨,2004,16(6)：6-8.
[78]殷晓雪,陈仲强,党耕盯,等.淫羊藿苷对人成骨细胞增殖与分化的影响[J].中国中药杂志,2005,30(4)：289-291.
[79]于波,杨久山,刘岩,等.淫羊藿苷对人成骨细胞的作用[J].中医正骨,2006,18(6)：17-18.
[80]张秀珍,杨黎娟.淫羊藿甙对大鼠成骨细胞护骨素、RANKL表达的影响[J].中华内分泌代谢杂志,2006,22(3)：222-225.
[81]朱志刚,宋利格,张秀珍.淫羊藿总黄酮对去卵巢大鼠骨组织Ⅰ型胶原代谢及组织蛋白酶K表达的影响[J].中华内分泌代谢杂志,2006,22(3)：213-217.
[82]齐振熙.生髓饮Ⅱ号治疗绝经后骨质疏松症36例[J].福建中医学院学报,2000,10(3)；29-30
[83]邓伟民,贺扬淑,冯永佳.补肾中药治疗绝经后骨质疏松症疗效分析[J].中国骨质疏松杂志,1997.3(1)：64-66
[84]陈根生,蒋奇平,韩允柱,等.筋骨再造合剂治疗绝经后骨质疏松症临床观察[J].中国中医骨伤科杂志.2001.9(6)：49-51
[85]何文扬,蔡雪芬.狗脊散加减治疗绝经后骨质疏松症113例[J].中医药学刊,2004,22(7)：1316-1317
[86]史炜缤,曲克服.骨松Ⅰ号治疗绝经后骨质疏松症的初步临床观察[J].中国骨伤,1996,9(6)：3-5
[87]赵光,徐则李,邵琼星,等.利维爱及中药补肾法防治绝经后妇女骨质疏松症的临床对比研究[J].中国骨质疏松杂志,2004,10(3)：337-339
[88]刘忠厚.骨质疏松学[M].北京：科学出版社,1998：46
[89]陈华圣.绝经后骨质疏松症中医病机探讨及防治法则[J].四川中医,1998,16(1)：8-9
[90]齐振熙.辨证治疗绝经后骨质疏松症[J].中国中医骨伤科杂志,1998,6(3)：28-29
[91]陈维静,刘新梅.中医辨证治疗原发性骨质疏松症(附109例报告)[J].中医药研究,1999.15(3)：29-31
[92]梁克玉,魏玉玲.中药增骨汤序贯疗法治疗绝经后骨质疏松症[J].中医正骨,1999,11(1)：9-10
[93]栗明拥.骨质疏松症调养与护理[M].北京,中国中医药出版社,1999：37
[94]潘文宇,李艳慧.针灸加火针治疗绝经后骨质疏松56例[J].中医药学刊,2002,21(5)：811
[95]针灸治疗绝经后骨质疏松症疗效确切[J].册东中医杂志,1999,181/2：234
[96]贾育松.穴位注射治疗绝经后骨质疏松症初探[J].中国骨质疏松杂志,2003,9(2)：171-172
[97]倪克锋,詹强,周翔,等.足部反射区按摩治疗绝经后骨质疏松症40例[J].浙江中医杂志,2002,(6)：246
[98]崔三生.一种新型ADL量表可行性研究[J].中国康复,1996.11(4)：153
[99]刘飞,任平,徐雅丽,等.艾灸防治绝经后骨质疏松的实验研究[J].中国老年学杂志,2012,32(8)：1655-1656
[100]胡平安,石宝营,胡金安.补肾活血汤并离子透入治疗骨质疏松性腰背痛28例[J].四川中 医.1994,12(9)：43-44
[101]叶安娜.补肾壮骨汤治疗老年性骨质疏松症60例临床观察[J].新中医,2012,30(7)：52.
[102]张乃钙,韩旭华.中西医结合治疗绝经后骨质疏松症的研究[J].中国中医骨伤科杂志,1995,3(1)：14-16.
[103]钱祖稀.中药配合雌激素治疗绝经后骨质疏松症60例[J].实用中医杂志,1999,15(8)：31.
[104]李隆敏,周樱,邵幸署.丹参酮防治绝经后骨质疏松症[J].中国骨质疏松杂志,1996,2(1)：78.
[105]张琥,石关桐,徐震球.脉冲电磁场治疗骨质疏松症机制探讨[J].现代康复,2001,5(5)：74
[106]孙雯敏,王先平,张秀云,等.脉冲电磁场治疗绝经后骨质疏松症肠46例临床观察[J].河北医学,2001.7(11)：979-981
[107]陈兵,姜友昭,万萍,等.脉冲电磁场对绝经后骨质疏松症患者骨密度及腰背痛改善效果[J].中国临床康复,2004.8(3)：504-505
[108]Kudla}ekyS, Pietsch}n F, Bernecja} P, etal. The irt}act of a senior dancing program on spinal and peripheral bone mass.AmJ Phys Med Rehabi 1,1997,76:47781
[109]Bemben DA.Exercise interventions for osteoporosis prevention in postmenopausal women J Okla State Nod Assoc,1999,92:66-70.
[110]乔玉成.Cochrane评价：绝经后妇女骨质疏松运动干预效果的比较[J].中国体育科技,2010,46(6)：121-128
[111]黄妹,孟萍,蔡红卫.低频脉冲电磁场与雌激素联合应用治疗绝经后骨质疏松症[J].中国临床康复,2003.7(5)：1399-1400
[112]卓铁军,欧阳钢,申志祥,等.针药结合对绝经后骨质疏松症骨密度的影响[J].针灸临床杂志.2000,16(n)：1-2
[113]李锋.综合治疗绝经后骨质疏松症58例疗效观察[J].中医正骨,2003,15(8)：23
[114]袁慧,汪绿萍,李煜明.耳压加钙剂治疗绝经后骨质疏松症45例[J].南京中医药大学学报(自然科学版),2001.17(4)：247
[115]钱祖稀.中药配合雌激素治疗绝经后骨质疏松症60例[J].实用中医杂志,1999,15(8)：31
[116]徐栋梁,李佛保,杨忠汉,等.DAsRR程序治疗131例绝经后骨质疏松症妇女的5年临床研究[J].中国骨质疏松杂志,2002,8(4)：321-323
[117]陈玉平,刘雪琴,蔡德鸿.对社区中老年人骨质疏松症的健康教育效果评价[J].护理研究,2006,20(171)：650-652.
[118]段永敏.中西医结合治疗绝经后骨质疏松症32例[J].深圳中西医结合杂志,2010,20(1)：48-50.
[119]刘梅三.绝经期妇女骨质疏松症的自我预防及护理指导[J].实用医技杂志,2005,12(5)：911.
[120]孙美芝,陈燕.绝经后妇女骨质疏松症防治研究进展[J].齐鲁护理杂志,2012,18(13)：55-56
[121]杨霏,秦开蓉,范绮平,等.健康教育对绝经后骨质疏松症患者的影响[J].中国康复,2012,27(4)：308-309
[122]廖二元,伍贤平,罗湘杭,等.绝经后骨质疏松症的发病机制和临床诊断与治疗[J].中国科技奖 励,2008,(10)：46-47
[123]张亚军,刘忠原,张鹏.绝经后骨质疏松症流行病学研究进展[J].中国骨质疏松杂志,2010,16(3)：229-234.
[124]杨黎娟.雌激素抗骨质疏松的研究进展[J].国外医学内分泌分册,2004,31(2)：84-87
[125]廖琳,黎学松,蔡全辉,等.补肾生髓法治疗绝经后骨质疏松症的临床研究[J].中国中医药信息杂志,2004,11(4)：287-290
[126]林文彬：骨质疏松症的中医证型研究与探讨[J].台湾：中国中医临床医学杂志,2004：10(3)
[127]孙青凤.绝经后骨质疏松症的研究进展[D].成都中医药大学硕士学位论文,2005,31-32
[128]潘子昂.我国骨质疏松研究现状和展望[J].中国骨质疏松杂志,2005,10(1)：68
[129]邓伟民,贺扬淑,冯永佳.补肾中药治疗绝经后骨质疏松症疗效分析[J].中国骨质疏松杂志,1997,3(1)：64
[130]冯世纶,夏志道,吴文才.治痹补骨丹治疗绝经后骨质疏松症47例临床观察[J].中国骨质疏松杂志,1997,3(2)：59
[131]工菖生,许昕,金敬善,等.益肾坚骨丸治疗女性骨质疏松症的临床研究[J].中国骨质疏松杂志,1997,3(4)：61
[132]杜靖远,杨家玉,洪光祥,等.补肾密骨液防治绝经后妇女代谢性骨质丢失的初步临床研究[J].中国中医骨伤科,1994,2(4)：13
[133]陈大蓉,唐显着,郑坤渝,等.中药护骨合剂防治绝经后骨质疏松症的临床研究[J].中医杂志,1994,35(6)：359
[134]刘和娣,李恩,刘昆.补肾中药对骨质疏松大鼠CaBp-D9k基因及表达的影响[J].中国骨质疏松杂志,1996,2(3)：62
[135]崔家鹏,郑洪新,刘景峰,等.补肾中药对肾虚骨质疏松症大鼠红细胞膜PKC、Ca2+-Mg2+-ATP酶活性影响的实验研究[J].中国骨质疏松杂志,1997,3(3)：66
[136]杨燕萍,沈霖,杜靖远,等.补肾密骨液对切除卵巢大鼠实验性骨质疏松症骨质无机元素的影响[J].中国中医骨伤科杂志,1994,2(5)：10
[137]李恩,陶静华,刘和娣,等.补肾方药治疗骨质疏松的实验研究与临床观察[J].中国骨质疏松杂志,1996,2(4)：65
[138]李安东,贾冬,李绿华,等.骨疏康冲剂的药理学实验研究[J].中国骨质疏松杂志,1996,2(3)：55
[139]梁克玉,魏玉玲,郭邦富,等.中药增骨序贯疗法治疗绝经后骨质疏松症—附120例临床观察[J].中医正骨,1999,11(1)：9
[140]陈训华,危剑安,陈燕平,等.补肾方药对去卵巢鼠骨质疏松症防治作用的研究[J].中国骨伤,1998，11(2)：12